Gilead Sciences Inc

NASDAQ: GILD
$66.76
+$0.60 (+0.9%)
Closing price April 19, 2024
Gilead Sciences Inc is a leading biopharmaceutical company focused on developing and commercializing innovative medicines for life-threatening illnesses worldwide. With a strong emphasis on HIV/AIDS, COVID-19, viral hepatitis, and oncology, Gilead offers a range of treatments that address unmet medical needs. Notable products include Biktarvy, Veklury, and Yescarta. Founded in 1987 and based in Foster City, California, Gilead also engages in significant partnerships to advance its research and development efforts.
With a recession likely on the way, health care is the place to be in 2023 for long-term investors looking for growth and income. These seven industry leaders offer solid total return potential in a...
Given that the Nasdaq has only twice had two down years in a row, the five highest-yielding stocks in the index offer a contrarian angle for 2023 for growth and income investors looking for a way...
Wednesday's top analyst upgrades and downgrades included Amazon, AMC Entertainment, Apollo Global Management, Apple, Block, Capital One Financial, Carlyle, CVS Health, Etsy, Fox, Gilead Sciences,...
Wednesday's top analyst upgrades and downgrades included Affirm, American Express, Block, Centene, Etsy, Gilead Sciences, KeyCorp, Norwegian Cruise Line, Okta, PayPal, Philip Morris International,...
Friday's top analyst upgrades and downgrades included ADT, Costco Wholesale, CrowdStrike, Gilead Sciences, Liberty Global, Otis Worldwide, PagSeguro Digital, Palo Alto Networks, Salesforce, Sunrun,...
Investors may be able to ride a potential Santa Claus rally for the balance of 2022. These five high-yielding Nasdaq stocks have some solid defensive qualities and are offering among the best entry...
Monday’s additional top analyst upgrades and downgrades were on Advanced Micro Devices, Amgen, BioMarin Pharmaceutical, Caterpillar, Gilead Sciences, Hanesbrands, Honeywell International, Keurig Dr...
Friday’s additional top analyst upgrades and downgrades were on Axalta Coating Systems, Caterpillar, DigitalOcean, Edwards Lifesciences, First Solar, Gilead Sciences, Intel, Stanley Black & Decker,...
These are seven great companies that Wall Street for one reason or another just does not like. Yet, their big and dependable dividends and solid positions in their respective sectors make them very...
Tuesday's top analyst upgrades and downgrades included Ally Financial, CarMax, Dominion Energy, Dynatrace, Exelon, GigaCloud Technology, Gilead Sciences, Intuit, KKR, Lowe’s Companies, Morgan...
One big advantage to buying beaten-down stocks with substantial dividends is that investors are paid to wait for the recovery. These eight well-known stocks now look ripe for the picking, and all are...
Given record inflation and rising interest rates, buying stocks that will pay dependable dividends until the economic mess is sorted out makes total sense now. These seven stocks can withstand...
The bear market rally that started in June is over and it is clearly a time to move to safer dividend stocks. These eight outstanding health care stocks make sense for worried investors now as they...
Wednesday’s top analyst upgrades and downgrades included Apple, Carvana, Elanco Animal Health, Gilead Sciences, Home Depot, Park Hotels & Resorts, Shoals Technologies, SNDL, SITE Centers and UDR.
Thursday’s top analyst upgrades and downgrades included Advanced Micro Devices, Baxter International, Caesars Entertainment, Electronic Arts, Exact Sciences, Gilead Sciences, Intel, JetBlue...